Antimicrobial activity of telavancin against Enterococcus faecalis, E. faecium and E. avium: results from a European surveillance program (2007)
Antimicrobial activity of telavancin against Enterococcus faecalis, E. faecium and E. avium: results from a European surveillance program (2007), Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Activity of telavancin tested against viridans group and beta-haemolytic streptococci, and multidrug-resistant Streptococcus pneumoniae
Activity of telavancin tested against viridans group and beta-haemolytic streptococci, and multidrug-resistant Streptococcus pneumoniae, Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Antimicrobial activity of telavancin and comparator agents tested against recently isolated (2007) European Staphylococcus aureus and coagulase-negative staphylococci
Antimicrobial activity of telavancin and comparator agents tested against recently isolated (2007) European Staphylococcus aureus and coagulase-negative staphylococci, Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Dalbavancin (DECIDE) tested against indicated Gram-positive species in European medical centres: results from France
Dalbavancin (DECIDE) tested against indicated Gram-positive species in European medical centres: results from France, Lead author: Leclercq, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Comparative activity of dalbavancin tested against indicated Gram-positive species in Europe: results from two Spanish medical centres (DECIDE Program)
Comparative activity of dalbavancin tested against indicated Gram-positive species in Europe: results from two Spanish medical centres (DECIDE Program), Lead author: Canton R, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Definition of wildtype MIC distributions for targeted species for determination of optimal dosing for zabofloxacin, a novel fluoronaphthyridone
Definition of wildtype MIC distributions for targeted species for determination of optimal dosing for zabofloxacin, a novel fluoronaphthyridone, Lead author: Jones RN, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Antimicrobial activity of ceftobiprole tested against leading European bacterial pathogens: results from an international surveillance programme (2005-2006)
Antimicrobial activity of ceftobiprole tested against leading European bacterial pathogens: results from an international surveillance programme (2005-2006), Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Enhanced activity of daptomycin and vancomycin combined with imipenem or oxacillin against community-acquired MRSA isolates
Enhanced activity of daptomycin and vancomycin combined with imipenem or oxacillin against community-acquired MRSA isolates, Lead author: Jones RN, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Rapid emergence and dissemination of blaCTX-M among Enterobacteriaceae in USA medical centres: report from the MYSTIC Program (2007)
Rapid emergence and dissemination of blaCTX-M among Enterobacteriaceae in USA medical centres: report from the MYSTIC Program (2007), Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Resistance surveillance of bacterial pathogens from North American patients hospitalised with pneumonia: a 10-year report from the SENTRY Program (1997-2006)
Resistance surveillance of bacterial pathogens from North American patients hospitalised with pneumonia: a 10-year report from the SENTRY Program (1997-2006), Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Escalating resistance among non-fermentative Gram-negative bacilli: Report from the North American SENTRY Antimicrobial Surveillance Program (1997-2006)
Escalating resistance among non-fermentative Gram-negative bacilli: Report from the North American SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Trends in prevalence and antimicrobial susceptibilities among skin and skin structure infection pathogens in North America: Report from the SENTRY Program (1997-2005)
Trends in prevalence and antimicrobial susceptibilities among skin and skin structure infection pathogens in North America: Report from the SENTRY Program (1997-2005), Lead author: Moet G, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Acinetobacter spp. infections: the Latin American scenario in the SENTRY Antimicrobial Surveillance Program (1997-2006)
Acinetobacter spp. infections: the Latin American scenario in the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Gales AC, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Potency and spectrum of tigecycline tested against bacterial pathogens producing skin and skin structure infections in European medical centres, including community-acquired methicillin-resistant S. aureus
Potency and spectrum of tigecycline tested against bacterial pathogens producing skin and skin structure infections in European medical centres, including community-acquired methicillin-resistant S. aureus, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
In vitro activity of tigecycline tested against pneumonia pathogens from patients hospitalised in European medical centres, including multidrug-resistant Acinetobacter spp.
In vitro activity of tigecycline tested against pneumonia pathogens from patients hospitalised in European medical centres, including multidrug-resistant Acinetobacter spp., Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Tigecycline activity tested against bacterial isolates causing bloodstream infections in European medical centres
Tigecycline activity tested against bacterial isolates causing bloodstream infections in European medical centres, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Analysis of resistance and vancomycin "reverse creep" in Latin American Staphylococcus aureus: ten-year report of the SENTRY Antimicrobial Surveillance Program (1997-2006)
Analysis of resistance and vancomycin "reverse creep" in Latin American Staphylococcus aureus: ten-year report of the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Picao, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Frequency and antimicrobial susceptibility profile of vancomycin-resistant enterococci from Latin America: a report from the SENTRY Antimicrobial Surveillance Program (1997-2006)
Frequency and antimicrobial susceptibility profile of vancomycin-resistant enterococci from Latin America: a report from the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Gales AC, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Prevalence of vancomycin-resistant Enterococcus spp. and associated resistance patterns among isolates collected over a decade of SENTRY Program surveillance in North America
Prevalence of vancomycin-resistant Enterococcus spp. and associated resistance patterns among isolates collected over a decade of SENTRY Program surveillance in North America, Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Genetic characterisation of the new blaVIM-18 and comparative antimicrobial susceptibility profile of VIM-18 with highest homologous VIM-variant, VIM-2: report from the SENTRY Antimicrobial Surveillance Program
Genetic characterisation of the new blaVIM-18 and comparative antimicrobial susceptibility profile of VIM-18 with highest homologous VIM-variant, VIM-2: report from the SENTRY Antimicrobial Surveillance Program, Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
High carbapenem resistance among Pseudomonas aeruginosa from India: a national epidemic of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, -11 and new VIM-18)
High carbapenem resistance among Pseudomonas aeruginosa from India: a national epidemic of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, -11 and new VIM-18), Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
blaVIM-2-carrying integron among Enterobacteriaceae isolates in Mexico: report from the SENTRY Antimicrobial Surveillance Program
blaVIM-2-carrying integron among Enterobacteriaceae isolates in Mexico: report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Wide variation in rates of ESBL production among Escherichia coli causing bacteraemia in the Asia-Pacific region: A SENTRY Program Report
Wide variation in rates of ESBL production among Escherichia coli causing bacteraemia in the Asia-Pacific region: A SENTRY Program Report, Lead author: Bell JM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Occurrence and resistance in pathogens from hospitalised patients with pneumonia in the Asia-Pacific region: a SENTRY Program Report (2006)
Occurrence and resistance in pathogens from hospitalised patients with pneumonia in the Asia-Pacific region: a SENTRY Program Report (2006), Lead author: Bell JM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain
Preliminary Microbiology Results from a Phase III Omiganan Pentahydrochloride Clinical Trial: In Vitro Activity Against Bacterial and Fungal Pathogens
Preliminary Microbiology Results from a Phase III Omiganan Pentahydrochloride Clinical Trial: In Vitro Activity Against Bacterial and Fungal Pathogens, Lead author: Fritsche TR, presented at 18th annual Society for Healthcare Epidemiology of America, April 5 – 8, 2008, Orlando, FL
Daptomycin Activity Tested Against Gram-Positive Cocci Isolated in Canadian Medical Centers (2004-2007)
Daptomycin Activity Tested Against Gram-Positive Cocci Isolated in Canadian Medical Centers (2004-2007), Lead author: Roscoe D, presented at 2008 Canada AMMI Conference, February 27 – March 2, 2008, Vancouver, Canada
Antimicrobial Activity and Spectrum of Daptomycin and Comparator Agents Tested Against Gram-Positive Organisms Collected from Patients with Cancer
Antimicrobial Activity and Spectrum of Daptomycin and Comparator Agents Tested Against Gram-Positive Organisms Collected from Patients with Cancer, Lead author: Sader HS, presented at MD Anderson Second Infections in Cancer Symposium, February 21-23, 2008, Houston, TX
Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. by Chin JN, Jones RN, Sader HS, Savage PB and Rybak MJ published in J. Antimicrob. Chemother. 2008; 61 (2): 365-370
Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acintobacter baumannii strains in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance Program.
Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acintobacter baumannii strains in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Wanger A, Kruzel M, Deshpande LM and Jones RN published in J. Clin. Microbiol. 2008; 46 (9): 3179-3180
RmtD 16S RNA methylase in epidemiologically unrelated SPM-1-producing Pseudomonas aeruginosa isolates from Brazil.
RmtD 16S RNA methylase in epidemiologically unrelated SPM-1-producing Pseudomonas aeruginosa isolates from Brazil. by Castanheira M, Fritsche TR, Sader HS and Jones RN published in Antimicrob. Agents Chemother. 2008; 52 (4): 1587-1588
Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: Molecular evaluation from the MYSTIC Program (2007).
Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: Molecular evaluation from the MYSTIC Program (2007). by Castanheira M, Mendes RE, Rhomberg PR and Jones RN published in Microb. Drug Resist. 2008; 14 (3): 211-216
Antimicrobial susceptibility of Gram-negative bacilli isolated in Brazilian hospitals participating in the SENTRY Program (2003-2008).
Antimicrobial susceptibility of Gram-negative bacilli isolated in Brazilian hospitals participating in the SENTRY Program (2003-2008). by Andrade S, Sader HS, Barth A, Ribeiro J, Zoccoli C, Pignatari AC and Gales AC published in Braz. J. Infect. Dis. 2008; 12 (Suppl. 2): S3-S9
Update of the activity of cefditoren and comparator oral ß-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).
Update of the activity of cefditoren and comparator oral ß-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006). by Fritsche TR, Biedenbach DJ, and Jones RN published in J. Chemother. 2008; 20 (2): 170-174
Evaluation of daptomycin, telavancin, teicoplanin and vancomycin activity in the presence of albumin or serum.
Evaluation of daptomycin, telavancin, teicoplanin and vancomycin activity in the presence of albumin or serum. by Tsuji BT, Leonard SN, Rhomberg PR and Rybak MJ published in Microbiol. Infect. Dis. 2008; 60 (4): 441-444
Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers.
Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers. by Sader HS, Watters AA, Fritsche TR and Jones RN published in J. Chemother. 2008; 20 (1): 28-32
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers.
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers. by Mendes RE, Sader HS, Deshpande L and Jones RN published in Diagn. Microbiol. Infect. Dis. 2008; 60 (4): 433-436
Pharmacokinetic and pharmacodynamic profile of ceftobiprole.
Pharmacokinetic and pharmacodynamic profile of ceftobiprole. by Lodise TP, Patel N, Renaud-Mutart A, Gorodecky E, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2008; 61 (1): 96-102
Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients.
Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients. by Sader HS, Fritsche TR and Jones RN published in J. Chemother. 2008; 20 (5): 570-576
Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico.
Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. by Garza-Ramos U, Tinoco P, Silva-Sanchez J, Morfin-Otero R, Rodriquez-Noriega E, Leon-Garnica G, Sader HS and Jones RN published in Int. J. Antimicrob. Agents 2008; 31 (1): 78-80.
Prevalence and genetic characterization of blaCTX-M among Klebsiella pneumoniae isolates collected in an intensive care unit in Brazil.
Prevalence and genetic characterization of blaCTX-M among Klebsiella pneumoniae isolates collected in an intensive care unit in Brazil. by Do Carmo Filho JR, Silva RM, Castanheira M, Tognim MCB, Gales AC and Sader HS published in J. Chemother. 2008; 20 (5): 600-603
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2005-2006). by Fritsche TR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2008; 61 (1): 86-95
Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States.
Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States. by Biedenbach DJ, Jones RN and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2008; 61 (2): 240-244
Comparative activity of meropenem in US medical centers (2007): Initiating the 2nd decade of MYSTIC Program surveillance.
Comparative activity of meropenem in US medical centers (2007): Initiating the 2nd decade of MYSTIC Program surveillance. by Jones RN, Kirby JT and Rhomberg PR published in Diagn. Microbiol. Infect. Dis. 2008; 61 (2):203-213
Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. by Fritsche TR, Rhomberg PR, Sader HS and Jones RN published in J. Antimicrob. Chemother. 2008; 61 (5): 1092-1098
In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate and -resistant Staphylococcus aureus.
In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate and -resistant Staphylococcus aureus. by Fritsche TR, Rhomberg PR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2008; 60 (4): 399-403
Antimicrobial activities of tigecycline and other broad spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program.
Antimicrobial activities of tigecycline and other broad spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Sader HS, Deshpande LM, Fritsche TR and Jones RN published in Antimicrob. Agents Chemother. 2008; 52 (2): 570-573
Novel ß-lactams.
Novel ß-lactams. by Gales AC and Sader HS published in Braz. J. Infect. Dis. 2008; 12 (Suppl. 2): S46-S58
Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis.
Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis. by Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J and Drusano GL published in Diagn. Microbiol. Infect. Dis. 2008; 61 (1): 13-20
Update of the in vitro activity of daptomycin tested against 6,710 Gram-positive cocci isolated in North America (2006).
Update of the in vitro activity of daptomycin tested against 6,710 Gram-positive cocci isolated in North America (2006). by Castanheira M, Jones RN and Sader HS published in Diagn. Microbiol. Infect. Dis. 2008; 61 (2): 235-239
IMP-producing Pseudomonas aeruginosa strain isolated in a US medical center: A recent arrival from Mexico.
IMP-producing Pseudomonas aeruginosa strain isolated in a US medical center: A recent arrival from Mexico. by Martin CA, Morita K, Ribes JA, Deshpande LM, Sader HS and Castanheira M published in Antimicrob. Agents Chemother. 2008; 52 (6): 2289-2290
